Industry Research Reports
Automatic Breast Ultrasound Diagnosis Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-06-16
Pages: 149 Pages
Report ld: 6743288
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Automatic Breast Ultrasound Diagnosis Systems Market Size(US$)
CAGR 2026-2032
8.7%
Market Size,2032
USD 4,113
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Automatic Breast Ultrasound Diagnosis Systems was estimated to be worth US$ 2312 million in 2025 and is projected to reach US$ 4113 million, growing at a CAGR of 8.7% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Automatic Breast Ultrasound Diagnosis Systems cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. The automated breast volume scanner (ABVS) segment is expected to hold the largest share during the forecast period, ABVS uses a scanner to precisely examine lactiferous ducts and evaluate breast volume images by high frequency ultrasound. The non-radioactivity, efficiency, repeatability and 3D reconstruction offered by this ultrasound system are just a few of its many advantages. Demand will rise as patient preference for minimally invasive diagnostic procedures increases. Real-time imaging support enables the chain of command. Other benefits of ABVS include faster, less painful surgery and improved diagnostic accuracy, leading to earlier breast cancer diagnosis. The results of this technique can be used for insightful preoperative surgical planning. The hospital segment accounted for the highest share in 2020 and is expected to maintain this trend over the forecast period owing to increasing patient population, faster availability of medical instruments and equipment, and presence of skilled personnel. The use of ABUS in hospitals is receiving increasing attention as a means of meeting the diagnostic needs of patients. Increased awareness of regular cancer screening tests among young and middle-aged women will drive demand for ABUS and ABVS in these healthcare facilities as pregnant women are unable to undergo mammograms due to radiation risks and hospitals are installing ABUS to provide a safer diagnostic option .
This report provides a comprehensive view of the global market for Automatic Breast Ultrasound Diagnosis Systems, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Automatic Breast Ultrasound Diagnosis Systems market size, estimations, and forecasts are presented in terms of sales volume (Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Automatic Breast Ultrasound Diagnosis Systems.
MARKET SEGMENTATION
By Company
- GE Healthcare
- Siemens
- Hitachi
- SonoCiné
- Koninklijke Philips
- QView Medical
- Seno Medical Instruments
- Volpara Solutions
- Delphinus Medical Technologies
- CapeRay
- SuperSonic Imagine
- Nova Medical Imaging Technology
- SIUI
- Theraclion
- Real Imaging
- MetriTrack
- Toshiba
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Automated Breast Ultrasound Systems
- Automated Breast Volume Scanner
Segment by Application
- Hospitals
- Diagnostic Imaging Laboratories
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Automatic Breast Ultrasound Diagnosis Systems manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Automatic Breast Ultrasound Diagnosis Systems sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Automatic Breast Ultrasound Diagnosis Systems sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Automatic Breast Ultrasound Diagnosis Systems Product Introduction
1.2 Global Automatic Breast Ultrasound Diagnosis Systems Market Size Forecast
1.2.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value (2021–2032)
1.2.2 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume (2021–2032)
1.2.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Price (2021–2032)
1.3 Automatic Breast Ultrasound Diagnosis Systems Market Trends & Drivers
1.3.1 Automatic Breast Ultrasound Diagnosis Systems Industry Trends
1.3.2 Automatic Breast Ultrasound Diagnosis Systems Market Drivers & Opportunities
1.3.3 Automatic Breast Ultrasound Diagnosis Systems Market Challenges
1.3.4 Automatic Breast Ultrasound Diagnosis Systems Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Automatic Breast Ultrasound Diagnosis Systems Players Revenue Ranking (2025)
2.2 Global Automatic Breast Ultrasound Diagnosis Systems Revenue by Company (2021–2026)
2.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume Ranking of Players (2025)
2.4 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume by Company (2021–2026)
2.5 Global Automatic Breast Ultrasound Diagnosis Systems Average Price by Company (2021–2026)
2.6 Key Manufacturers Automatic Breast Ultrasound Diagnosis Systems Manufacturing Base and Headquarters
2.7 Key Manufacturers Automatic Breast Ultrasound Diagnosis Systems Product Offerings
2.8 Key Manufacturers Start of Mass Production of Automatic Breast Ultrasound Diagnosis Systems
2.9 Automatic Breast Ultrasound Diagnosis Systems Market Competitive Analysis
2.9.1 Automatic Breast Ultrasound Diagnosis Systems Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Automatic Breast Ultrasound Diagnosis Systems Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Automatic Breast Ultrasound Diagnosis Systems revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Automatic Breast Ultrasound Diagnosis Systems Market Classification
3.1 Introduction by Type
3.1.1 Automated Breast Ultrasound Systems
3.1.2 Automated Breast Volume Scanner
3.1.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value by Type
3.1.3.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value, by Type (2021–2032)
3.1.3.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value, by Type (%), 2021–2032
3.1.4 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume by Type
3.1.4.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume, by Type (2021–2032)
3.1.4.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume, by Type (%), 2021–2032
3.1.5 Global Automatic Breast Ultrasound Diagnosis Systems Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Diagnostic Imaging Laboratories
4.2 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value by Application
4.2.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value, by Application (2021–2032)
4.2.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value, by Application (%), 2021–2032
4.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume by Application
4.3.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume, by Application (2021–2032)
4.3.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume, by Application (%), 2021–2032
4.4 Global Automatic Breast Ultrasound Diagnosis Systems Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value by Region
5.1.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value by Region (2021–2026)
5.1.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value by Region (2027–2032)
5.1.4 Global Automatic Breast Ultrasound Diagnosis Systems Sales Value by Region (%), 2021–2032
5.2 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume by Region
5.2.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume by Region (2021–2026)
5.2.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume by Region (2027–2032)
5.2.4 Global Automatic Breast Ultrasound Diagnosis Systems Sales Volume by Region (%), 2021–2032
5.3 Global Automatic Breast Ultrasound Diagnosis Systems Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
5.4.2 North America Automatic Breast Ultrasound Diagnosis Systems Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
5.5.2 Europe Automatic Breast Ultrasound Diagnosis Systems Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
5.6.2 Asia Pacific Automatic Breast Ultrasound Diagnosis Systems Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
5.7.2 South America Automatic Breast Ultrasound Diagnosis Systems Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
5.8.2 Middle East & Africa Automatic Breast Ultrasound Diagnosis Systems Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Automatic Breast Ultrasound Diagnosis Systems Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Automatic Breast Ultrasound Diagnosis Systems Sales Value and Sales Volume
6.2.1 Key Countries/Regions Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
6.2.2 Key Countries/Regions Automatic Breast Ultrasound Diagnosis Systems Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
6.3.2 United States Automatic Breast Ultrasound Diagnosis Systems Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Automatic Breast Ultrasound Diagnosis Systems Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
6.4.2 Europe Automatic Breast Ultrasound Diagnosis Systems Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Automatic Breast Ultrasound Diagnosis Systems Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
6.5.2 China Automatic Breast Ultrasound Diagnosis Systems Sales Value by Type (%), 2025 vs 2032
6.5.3 China Automatic Breast Ultrasound Diagnosis Systems Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
6.6.2 Japan Automatic Breast Ultrasound Diagnosis Systems Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Automatic Breast Ultrasound Diagnosis Systems Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
6.7.2 South Korea Automatic Breast Ultrasound Diagnosis Systems Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Automatic Breast Ultrasound Diagnosis Systems Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
6.8.2 Southeast Asia Automatic Breast Ultrasound Diagnosis Systems Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Automatic Breast Ultrasound Diagnosis Systems Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Automatic Breast Ultrasound Diagnosis Systems Sales Value, 2021–2032
6.9.2 India Automatic Breast Ultrasound Diagnosis Systems Sales Value by Type (%), 2025 vs 2032
6.9.3 India Automatic Breast Ultrasound Diagnosis Systems Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Company Information
7.1.2 GE Healthcare Introduction and Business Overview
7.1.3 GE Healthcare Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 GE Healthcare Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.1.5 GE Healthcare Recent Developments
7.2 Siemens
7.2.1 Siemens Company Information
7.2.2 Siemens Introduction and Business Overview
7.2.3 Siemens Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Siemens Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.2.5 Siemens Recent Developments
7.3 Hitachi
7.3.1 Hitachi Company Information
7.3.2 Hitachi Introduction and Business Overview
7.3.3 Hitachi Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Hitachi Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.3.5 Hitachi Recent Developments
7.4 SonoCiné
7.4.1 SonoCiné Company Information
7.4.2 SonoCiné Introduction and Business Overview
7.4.3 SonoCiné Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 SonoCiné Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.4.5 SonoCiné Recent Developments
7.5 Koninklijke Philips
7.5.1 Koninklijke Philips Company Information
7.5.2 Koninklijke Philips Introduction and Business Overview
7.5.3 Koninklijke Philips Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Koninklijke Philips Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.5.5 Koninklijke Philips Recent Developments
7.6 QView Medical
7.6.1 QView Medical Company Information
7.6.2 QView Medical Introduction and Business Overview
7.6.3 QView Medical Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 QView Medical Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.6.5 QView Medical Recent Developments
7.7 Seno Medical Instruments
7.7.1 Seno Medical Instruments Company Information
7.7.2 Seno Medical Instruments Introduction and Business Overview
7.7.3 Seno Medical Instruments Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Seno Medical Instruments Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.7.5 Seno Medical Instruments Recent Developments
7.8 Volpara Solutions
7.8.1 Volpara Solutions Company Information
7.8.2 Volpara Solutions Introduction and Business Overview
7.8.3 Volpara Solutions Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Volpara Solutions Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.8.5 Volpara Solutions Recent Developments
7.9 Delphinus Medical Technologies
7.9.1 Delphinus Medical Technologies Company Information
7.9.2 Delphinus Medical Technologies Introduction and Business Overview
7.9.3 Delphinus Medical Technologies Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Delphinus Medical Technologies Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.9.5 Delphinus Medical Technologies Recent Developments
7.10 CapeRay
7.10.1 CapeRay Company Information
7.10.2 CapeRay Introduction and Business Overview
7.10.3 CapeRay Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 CapeRay Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.10.5 CapeRay Recent Developments
7.11 SuperSonic Imagine
7.11.1 SuperSonic Imagine Company Information
7.11.2 SuperSonic Imagine Introduction and Business Overview
7.11.3 SuperSonic Imagine Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 SuperSonic Imagine Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.11.5 SuperSonic Imagine Recent Developments
7.12 Nova Medical Imaging Technology
7.12.1 Nova Medical Imaging Technology Company Information
7.12.2 Nova Medical Imaging Technology Introduction and Business Overview
7.12.3 Nova Medical Imaging Technology Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Nova Medical Imaging Technology Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.12.5 Nova Medical Imaging Technology Recent Developments
7.13 SIUI
7.13.1 SIUI Company Information
7.13.2 SIUI Introduction and Business Overview
7.13.3 SIUI Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 SIUI Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.13.5 SIUI Recent Developments
7.14 Theraclion
7.14.1 Theraclion Company Information
7.14.2 Theraclion Introduction and Business Overview
7.14.3 Theraclion Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Theraclion Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.14.5 Theraclion Recent Developments
7.15 Real Imaging
7.15.1 Real Imaging Company Information
7.15.2 Real Imaging Introduction and Business Overview
7.15.3 Real Imaging Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Real Imaging Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.15.5 Real Imaging Recent Developments
7.16 MetriTrack
7.16.1 MetriTrack Company Information
7.16.2 MetriTrack Introduction and Business Overview
7.16.3 MetriTrack Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 MetriTrack Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.16.5 MetriTrack Recent Developments
7.17 Toshiba
7.17.1 Toshiba Company Information
7.17.2 Toshiba Introduction and Business Overview
7.17.3 Toshiba Automatic Breast Ultrasound Diagnosis Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Toshiba Automatic Breast Ultrasound Diagnosis Systems Product Offerings
7.17.5 Toshiba Recent Developments
8 Industry Chain Analysis
8.1 Automatic Breast Ultrasound Diagnosis Systems Industrial Chain
8.2 Automatic Breast Ultrasound Diagnosis Systems Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Automatic Breast Ultrasound Diagnosis Systems Sales Model
8.5.2 Sales Channels
8.5.3 Automatic Breast Ultrasound Diagnosis Systems Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2026
The global Automatic Breast Ultrasound Diagnosis Systems market was valued at US$ 2312 million in 2025 and is anticipated to reach US$ 4113 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 129
USD 2900.00
(Single User License)
Global Automatic Breast Ultrasound Diagnosis Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Automatic Breast Ultrasound Diagnosis Systems market size was US$ 2144 million in 2024 and is forecast to a readjusted size of US$ 3814 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 104
USD 4250.00
(Single User License)
Global Automatic Breast Ultrasound Diagnosis Systems Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Automatic Breast Ultrasound Diagnosis Systems market is projected to grow from US$ 2144 million in 2024 to US$ 3814 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 171
USD 4900.00
(Single User License)
Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2025
The global market for Automatic Breast Ultrasound Diagnosis Systems was valued at US$ 2144 million in the year 2024 and is projected to reach a revised size of US$ 3814 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published Date: 2025-01-16
Pages: 99
USD 2900.00
(Single User License)
Automatic Breast Ultrasound Diagnosis Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Automatic Breast Ultrasound Diagnosis Systems was estimated to be worth US$ 2144 million in 2024 and is forecast to a readjusted size of US$ 3814 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 139
USD 3950.00
(Single User License)
Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2024
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
Published Date: 2024-01-20
Pages: 101
USD 2900.00
(Single User License)
Automatic Breast Ultrasound Diagnosis Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
Published Date: 2024-01-11
Pages: 141
USD 3950.00
(Single User License)
Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2026
The global Automatic Breast Ultrasound Diagnosis Systems market was valued at US$ 2312 million in 2025 and is anticipated to reach US$ 4113 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-04-17
Pages: 129
USD 2900.00 (Single User License)Global Automatic Breast Ultrasound Diagnosis Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Automatic Breast Ultrasound Diagnosis Systems market size was US$ 2144 million in 2024 and is forecast to a readjusted size of US$ 3814 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 104
USD 4250.00 (Single User License)Global Automatic Breast Ultrasound Diagnosis Systems Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Automatic Breast Ultrasound Diagnosis Systems market is projected to grow from US$ 2144 million in 2024 to US$ 3814 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 171
USD 4900.00 (Single User License)Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2025
The global market for Automatic Breast Ultrasound Diagnosis Systems was valued at US$ 2144 million in the year 2024 and is projected to reach a revised size of US$ 3814 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published: 2025-01-16
Pages: 99
USD 2900.00 (Single User License)Automatic Breast Ultrasound Diagnosis Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Automatic Breast Ultrasound Diagnosis Systems was estimated to be worth US$ 2144 million in 2024 and is forecast to a readjusted size of US$ 3814 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 139
USD 3950.00 (Single User License)Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2024
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
Published: 2024-01-20
Pages: 101
USD 2900.00 (Single User License)Automatic Breast Ultrasound Diagnosis Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
Published: 2024-01-11
Pages: 141
USD 3950.00 (Single User License)
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now